Brief: 3D Medicines Updates On Exclusive License Agreement Between Co And Sellas Life Sciences

Sellas Life Sciences

27/12/2023 24:35

Dec 27 (Reuters) - 3D Medicines Inc  1244.HK :
    * UPDATES ON  EXCLUSIVE LICENSE AGREEMENT BETWEEN CO AND 
SELLAS
LIFE SCIENCES
    * PRESENTLY UNABLE TO ASSESS POTENTIAL IMPACT OF
ARBITRATION, IF
ANY, ON GROUP AT THIS STAGE
    * CONSIDERS THAT CLAIMS AND ALLEGATIONS FROM CLAIMANTS ARE
GROUNDLESS AND UNJUSTIFIED
    * WILL STRENUOUSLY CONTEST ARBITRATION

Further company coverage:  1244.HK